Rotterdam, The Netherlands (6 November 2025) - IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, today announces its first nine months 2025 results. HIGHLIGHTS Gross profit up by 2% to EUR 927 million (+5% on a constant currency basis)Operating EBITA down by 2% to EUR 394 million (+1% on a constant currency basis)Free cash flow of EUR 284 million (first nine months 2024: EUR 299 million)Cash earnings per share at EUR 4.16 ...

Rotterdam, The Netherlands (22 October 2025) We are pleased to inform you that IMCD will publish its First Nine Months 2025 results on Thursday 6 November 2025 at 07.00 am CET. Following the publication, Marcus Jordan (CEO) and Hans Kooijmans (CFO) will host an analyst conference call & webcast starting at 09.00 am CET. The presentation will be made available on the publication date at 7:00 am CET on our website under the Investor Relations section. A replay of the webcast will be uploaded to our website s ...

Core Insights - IMCD N.V. celebrates its 30th anniversary, marking significant growth from its foundation in Rotterdam in 1995 to becoming a global leader in specialty chemicals distribution with over 5,200 employees across 60+ countries [1][2][3] Company Overview - IMCD is recognized as a leading global partner for the distribution and formulation of specialty chemicals and ingredients, emphasizing sustainable value in the supply chain [4] - The company reported revenues of EUR 4,728 million in 2024, and its shares are traded on Euronext Amsterdam, included in the Dutch ESG AEX index [5] Milestones - Key milestones include surpassing €1 billion in revenue in 2011, listing on Euronext Amsterdam in 2014, and strategic acquisitions such as MF Cachat in the US and Signet in India [2][6] - The company has expanded its global presence significantly, with a focus on sustainability initiatives and partnerships [2][6] Leadership and Vision - The current CEO, Marcus Jordan, emphasizes the importance of partnerships and the entrepreneurial spirit that has driven IMCD's success over the past three decades [3] - The leadership transition from founder Piet van der Slikke to Valerie Diele-Braun and later Marcus Jordan marks a new chapter for the company [6]

Core Insights - IMCD N.V. has signed an agreement to acquire 100% of the shares in Tillmanns S.p.A., enhancing its market presence in Italy and unlocking growth potential across industrial and food markets [1][4]. Company Overview - Tillmanns, founded in 1940 and headquartered in Milan, Italy, is a well-established distributor of specialty chemicals, serving key markets such as coatings, construction, food & nutrition, and water treatment [2]. - In 2024, Tillmanns reported annual revenues of approximately EUR 143 million and employs a skilled team of 78 people [3]. Strategic Fit - The acquisition of Tillmanns is a strategic fit for IMCD, as it increases scale and market presence in Italy, complementing IMCD's ambition to deliver value-driven solutions and technical support [4]. - Marcus Jordan, CEO of IMCD, emphasized that Tillmanns brings local expertise, a loyal customer base, and a strong growth platform in industrial, water, and food applications [5]. Financial Performance - IMCD reported revenues of EUR 4,728 million in 2024 and has over 5,100 employees [7].

Core Insights - IMCD N.V. reported a forex adjusted gross profit growth of 7% and EBITA growth of 4% for the first half of 2025, demonstrating resilience in challenging macro-economic conditions [2][4] - The company completed six acquisitions across three regions to enhance its capabilities in core market segments [2][4] - Free cash flow decreased to EUR 173 million from EUR 221 million in the first half of 2024, indicating a decline in cash generation [4] - Cash earnings per share fell to EUR 2.94 from EUR 3.23 in the first half of 2024, reflecting a decrease in profitability per share [4] Financial Performance - Gross profit increased by 5% to EUR 634 million, with a 7% increase on a constant currency basis [4] - Operating EBITA rose by 2% to EUR 275 million, with a 4% increase on a constant currency basis [4] Strategic Developments - The company emphasized its asset-light business model and advanced digital and supply chain capabilities as key strengths for future positioning [2]

Core Viewpoint - IMCD N.V. has announced the acquisition of 100% of the shares in Trichem Healthcare Private Limited, Trichem Lifesciences Limited, and Chemistry & Health FZ LLC, enhancing its portfolio in the life-sciences industry, particularly in active pharmaceutical ingredients [1][4]. Company Overview - IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients, headquartered in Rotterdam, The Netherlands [5]. - In 2024, IMCD reported revenues of EUR 4,728 million and employed over 5,100 staff [6]. Trichem Overview - Trichem, founded in 1998 and based in Mumbai, India, specializes in supplying high-quality active pharmaceutical ingredients and pharmaceutical intermediates, along with regulatory assistance for the pharmaceutical markets in India [2]. - The company operates with 36 employees and generated annual revenue of approximately INR 1.7 billion (around EUR 18 million) for the financial year ending 31 March 2025, with 33% of this revenue derived from commission income [3]. Strategic Importance - The acquisition is positioned to strengthen IMCD's presence in the Indian market, which is a major supplier of generic drugs globally, and to leverage Trichem's market expertise and industry relationships [4].

Core Insights - IMCD N.V. has signed an agreement to acquire 100% of the shares in TECOM Ingredients S.A. [1] - The acquisition aims to enhance IMCD's presence in the Iberian market and expand its portfolio with complementary ingredients [3] Company Overview - IMCD is a global leader in the distribution and formulation of specialty chemicals and ingredients, headquartered in Rotterdam, The Netherlands [4] - In 2024, IMCD reported revenues of EUR 4,728 million and employed over 5,100 staff [5] TECOM Overview - TECOM, founded in 1996 and based in Molins de Rei, Spain, is a recognized distributor of ingredients and additives for the food industry, with annual revenues of approximately EUR 18 million in 2024 [2][3] - The company specializes in various applications, including savory, bakery, dairy, and health and nutrition products [2] Strategic Implications - The acquisition is expected to open new avenues for growth and enhance value for customers by combining the expertise of both companies [3] - The transaction is subject to customary closing conditions and is anticipated to close in the second quarter of 2025 [3]